Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Research Study on How Well Semaglutide Works in Adolescents With Overweight or Obesity

ClinicalTrials.gov ID: NCT04102189

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT04102189. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 20, 2026, 9:24 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Effect and Safety of Semaglutide 2.4 mg Once Weekly on Weight Management in Adolescents With Overweight or Obesity

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study will look at the change in teenagers' body weight from the start to the end of the study. This is to compare the effect on body weight in teenagers taking semaglutide (a new medicine) and teenagers taking "dummy" medicine. The teenagers in the study and their parents will also have talks with study staff about healthy food choices, how to be more physically active and what they can do to help the teenagers lose weight. The teenagers will either get semaglutide or "dummy" medicine - which treatment is decided by chance. The teenagers will take 1 injection every week, on the same day of the week for about 15 months. The study medicine is injected with a thin needle in a skin fold in the stomach, thigh or upper arm. The teenagers will have 17 clinic visits, will have blood samples taken and will have to complete questionnaires and keep a diary. All this will be explained before study start.

Study identification

NCT ID
NCT04102189
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Novo Nordisk A/S
Industry
Enrollment
201 participants

Conditions and interventions

Interventions

Drug · Other

Eligibility (public fields only)

Age range
12 Years to 17 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 7, 2019 (Actual)
Primary completion
Mar 25, 2022 (Actual)
Completion
Mar 28, 2022 (Actual)
Last update posted
Dec 11, 2025

2019 – 2022

United States locations

U.S. sites
23
U.S. states
16
U.S. cities
22
Facility City State ZIP Site status
Children's Hospital Los Angeles - Endocrinology Los Angeles California 90027 —
Solaris Clinical Research Meridian Idaho 83646 —
Pennington Biomed Res Ctr Baton Rouge Louisiana 70808-4124 —
DelRicht Research Gretna Louisiana 70053 —
Barry J. Reiner, MD LLC Baltimore Maryland 21229 —
Massachusetts General Hospital_Cary Boston Massachusetts 02114-2621 —
University of Minnesota_CPOM Minneapolis Minnesota 55414 —
University of Minnesota_Minneapolis Minneapolis Minnesota 55455 —
UBMD Peds-Div of Endo/Diabetes Buffalo New York 14203 —
WakeMed Childn Endo-Dbt_Raleig Raleigh North Carolina 27610 —
Valley Weight Loss Clinic Fargo North Dakota 58104 —
Aventiv Research Inc Columbus Ohio 43213 —
PriMed Clinical Research Dayton Ohio 45419 —
Geisinger Clinic Danville Pennsylvania 17822-2111 —
Children's Hosptl Philadelphia Philadelphia Pennsylvania 19104 —
UPMC Child Hosp-Pittsburgh Pittsburgh Pennsylvania 15224 —
Medical Research South, LLC_Cary Goose Creek South Carolina 29445 —
Greenville Hospital System Pediatric Endo Greenville South Carolina 29615 —
Monument Health Clinical Rsrch Rapid City South Dakota 57701 —
Discovery MM Services, Inc Houston Texas 77061 —
Univ Of Texas Hlth Science Cntr San Antonio Texas 78229 —
National Clin Res Inc. Richmond Virginia 23294 —
Marshfield Clinic Marshfield Wisconsin 54449 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 28 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04102189, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 11, 2025 · Synced Nov 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.